These Shared Resources have been instrumental in driving and allowing novel and cutting-edge research. One example is a novel investigator-developed and initiated trial on CAR T for T-cell malignancies. Additional examples include a large multi-center trial also based on fundamental research conducted in the SBCC; discovery of novel bioactive lipids; defining novel molecular mechanisms of post-translational modification; novel biomarkers for pancreatic cancer; and development of novel inhibitors of cancer-promoting pathways.
In 2019, SBCC leadership proposed a fourth shared resource, Advanced Imaging, that takes advantage of the history of Stony Brook in imaging research (e.g., contributing to the development of MRI, PET scanning and virtual colonoscopy) and the new investment in a Cyclotron. This was approved by the EAB. In 2020/2021, SBCC invested in the highly enabling and innovative MALDI imaging spectroscopy to support both the Biologic Mass Spectrometry and the Tissue Analytics Shared Resources. This was based on the outstanding research abilities in lipidomics, and it was enabled by a generous donation from The Kavita and Lalit Bahl Center for Metabolomics and Imaging.
Also, in 2020, it was decided through the updated 2020-2025 Strategic Plan to begin development of a new Bioinformatics Shared Resource. This also builds on the rising and exceptional strengths of Stony Brook in biomedical informatics and computational biology, and the very close relationships between the SBCC and the College of Engineering and Applied Sciences (CAES), which houses the departments of Biomedical Engineering, Biomedical Informatics, Computer Sciences and Applied Math (among several others).